+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Cellular Tumor Antigen p53 - Pipeline Review, H2 2019 - Product Thumbnail Image

Cellular Tumor Antigen p53 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 134 Pages
  • Global
From
From
From
Integrin Alpha 7 (ITGA7) - Pipeline Review, H1 2018 - Product Thumbnail Image

Integrin Alpha 7 (ITGA7) - Pipeline Review, H1 2018

  • Drug Pipelines
  • June 2018
  • 26 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more